Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Browsing Tag

to

37 posts
RRoche
Roche’s ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD
Read More

Roche’s ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD

  • 2026-04-22
Phase III METEOROID study met its primary endpoint in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)MOGAD is…
AAlps
Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight
Read More

Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight

  • 2026-04-18
KUALA LUMPUR, Malaysia, April 17, 2026 (GLOBE NEWSWIRE) — Alps Group Inc (the “Company” or “Alps Group”), the…
GGeneva
Geneva watch fair set to show war's effect on luxury sector
Read More

Geneva watch fair set to show war’s effect on luxury sector

  • 2026-04-15
GENEVA, Switzerland — The Geneva watch fair, the watchmaking industry’s biggest annual showcase, opened on Tuesday with the…
RRoche
Roche receives CE mark for new Elecsys NfL blood test to detect neuroinflammation in multiple sclerosis
Read More

Roche receives CE mark for new Elecsys NfL blood test to detect neuroinflammation in multiple sclerosis

  • 2026-04-13
The Elecsys NfL blood test detects neuroaxonal damage associated with neuroinflammation in adults diagnosed with relapsing remitting multiple…
SSwitzerland
"I had to leave home because there was nothing in l'Ampolla"
Read More

I had to leave home because there was nothing in l’Ampolla

  • 2026-04-11
BarcelonaOnce training and the gym session were over, Laia Ballesté Sciora (Ampolla, 1999) speaks to ARA at the…
GGeneva
US sanctions to hurt Cubans violate Geneva Conventions
Read More

US sanctions to hurt Cubans violate Geneva Conventions

  • 2026-04-05
Mark Weisbrot, Tribune News Service In the last year there have been a record number of legislative efforts…
RRoche
Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test to further safeguard the global blood supply
Read More

Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test to further safeguard the global blood supply

  • 2026-03-30
The cobas MPX-E test provides four critical results (for HIV, HCV, HBV, and HEV) in a single test,…
NNovartis
Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation
Read More

Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation

  • 2026-03-27
– Proposed acquisition strengthens Novartis immunology strategy in food allergy and other IgE-driven diseases     – Lead asset…
NNovartis
Excellergy to be acquired by Novartis for up to USD 2 billion to advance potentially first-in-class trifunctional effector cell response inhibitors
Read More

Excellergy to be acquired by Novartis for up to USD 2 billion to advance potentially first-in-class trifunctional effector cell response inhibitors

  • 2026-03-27
– Acquisition brings together Excellergy’s differentiated trifunctional allergic effector cell response inhibitors (ECRIs) and the development expertise of…
GGeneva
Carrera y Carrera to Exhibit at Haute Jewels Geneva 2026
Read More

Carrera y Carrera to Exhibit at Haute Jewels Geneva 2026

  • 2026-03-26
Madrid, Spain, March 26, 2026 — The Spanish jewellery house returns to the April showcase with four European…
SSwitzerland
SEALSQ Signs Letter of Intent to Acquire 100% of Miraex, a Swiss Quantum Interconnect Platform Company
Read More

SEALSQ Signs Letter of Intent to Acquire 100% of Miraex, a Swiss Quantum Interconnect Platform Company

  • 2026-03-24
Geneva, Switzerland, March 24, 2026 (GLOBE NEWSWIRE) — Strategic Acquisition via the SEALSQ Quantum Fund Strengthens its Quantum…
RRoche
A memorable moment: learners, educators, and Roche experts together at the Swiss Embassy’s Day of the Future.
Read More

Manila Bulletin – Swiss Embassy and Swiss Cultural Fund bring career discovery to Filipino students

  • 2026-03-23
The Embassy of Switzerland in the Philippines, together with the Swiss Cultural Fund and in collaboration with the…
Switzerland
www.europesays.com